Invex Therapeutics Ltd (ASX:IXC)
A$ 0.076 0.002 (2.7%) Market Cap: 5.71 Mil Enterprise Value: -440,000.00 PE Ratio: 0 PB Ratio: 1.09 GF Score: 0/100

Q1 2023 Invex Therapeutics Ltd Activities Report Call Transcript

Oct 27, 2022 / 01:00AM GMT
Release Date Price: A$0.6
Operator

Thank you for standing by, and welcome to the Invex Therapeutics Limited quarterly investor conference call. All participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session. (Operator instructions)

I'll now like to hand the conference over to Dr. Tom Duthy, Executive Director. Please go ahead.

Tom Duthy
Invex Therapeutics Ltd. - Executive Director

Thanks, Cameron, and good afternoon, everyone. It's my pleasure to present to you a summary of the company's financial performance and quarterly activity for the three months ended September 30, 2022, being our Q1 FY 2023.

I trust all of you on today's call have had a chance to read the announcement that was lodged with the ASX this morning. I'd like to provide an overview of our first-quarter performance and our outlook for the remainder of the 2022 calendar year.

And so I'd like to start with our financials before turning to our operational update. The company closed the quarter in a continued strong financial position with cash and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot